Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Vitamin Shoppe goes for IPO

This article was originally published in The Tan Sheet

Executive Summary

VS Holdings files a registration statement with the Securities and Exchange Commission seeking an initial public offering of common stock for the firm, which will be renamed Vitamin Shoppe Inc. According to the form filed July 23, Vitamin Shoppe increased its net sales from $436.5 million in fiscal 2005 to $601.5 million in fiscal 2008. The North Bergen, N.J.-based nutritional product retailer and marketer was founded as a single store in New York City in 1977 and now operates 425 U.S. locations. Following the IPO, Vitamin Shoppe intends to have its stock listed on the New York Stock Exchange under the ticker symbol "VSI.

You may also be interested in...



Vitamin Shoppe, Vitacost.com Emerge From IPOs With Healthy Sales

A pair of supplement retailers report strong sales growth during their first quarterly earnings calls as publicly traded companies, supporting the notion that many consumers consider nutritional products non-discretionary purchases

People In Brief

Vitamin Shoppe promotes Markee to CEO: Less than two months after filing for an initial public offering, Vitamin Shoppe Industries appoints Chairman Richard Markee as CEO. Markee will assume full responsibility for the North Bergen, N.J.-based retailer's day-to-day operations, including its retail and direct businesses, which brought in $601.5 million in fiscal 2008 net sales. Markee is an experienced executive, previously serving as interim CEO at Toys "R" Us, and is familiar with Vitamin Shoppe's operations. He served as non-executive chairman for the company since April 2007 and as a board member since 2006. He replaces Thomas Tolworthy, who will continue as VP of corporate strategy and business development. Vitamin Shoppe's parent firm, VS Holdings, requested clearance from the Securities and Exchange Commission for an IPO in July and plans to use the ticker symbol VSI (1"The Tan Sheet" July 27, 2009)

Biogen’s Big Day Arrives, But Aducanumab Results Don’t Answer Key Question

Biogen presented highly anticipated data in Alzheimer’s disease at CTAD for its Phase III EMERGE and ENGAGE studies, but one major question remains unanswered: will the FDA approve the drug? 

Topics

UsernamePublicRestriction

Register

PS103170

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel